Targeted Medical Pharma Inc (TRGM) financial statements (2021 and earlier)

Company profile

Business Address 2980 BEVERLY GLEN CIRCLE
LOS ANGELES, CA 90077
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8312492327
Cash and cash equivalents8312492327
Receivables328203269354
Inventory, net of allowances, customer advances and progress billings92127596478
Inventory92127596478
Prepaid expense  901
Prepaid expense and other current assets212
Other current assets330192372
Other undisclosed current assets   1,228
Total current assets:8335342,6302,599
Noncurrent Assets
Property, plant and equipment54107236340
Long-term investments and receivables   (386)
Due from related parties   (386)
Intangible assets, net (including goodwill)1,5401,8592,1332,319
Intangible assets, net (excluding goodwill)1,5401,8592,1332,319
Prepaid expense and other noncurrent assets27
Other undisclosed noncurrent assets   6,877
Total noncurrent assets:1,5941,9662,3689,177
TOTAL ASSETS:2,4272,5004,99811,775
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,05012,7319,7207,024
Accounts payable1,8641,4601,497 
Accrued liabilities8,1867,2745,655 
Employee-related liabilities 3,9972,568 
Accounts payable and other accrued liabilities 7,024
Debt2,1191,0931,458 
Derivative instruments and hedges, liabilities11829 
Due to related parties2,5042,504 5,033
Deferred tax liabilities   70
Other undisclosed current liabilities (3,997)53188
Total current liabilities:14,67512,35011,26112,315
Noncurrent Liabilities
Long-term debt and lease obligation104122755 
Long-term debt, excluding current maturities104122755 
Liabilities, other than long-term debt567  1,463
Deferred tax liabilities, net   1,077
Due to related parties567  386
Total noncurrent liabilities:6711227551,463
Total liabilities:15,34612,47212,01513,777
Stockholders' equity
Stockholders' equity attributable to parent, including:(12,895)(9,972)(7,018)(2,002)
Common stock28272623
Additional paid in capital17,03816,91915,97911,660
Accumulated deficit(29,961)(26,917)(23,022)(13,685)
Warrants and rights outstanding   188
Other undisclosed stockholders' equity attributable to parent   (188)
Stockholders' equity attributable to noncontrolling interest(23)   
Total stockholders' equity:(12,919)(9,972)(7,018)(2,002)
TOTAL LIABILITIES AND EQUITY:2,4272,5004,99811,775

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
5,2617,1129,5567,296
Cost of revenue
(Cost of Goods and Services Sold)
(2,096)(2,217)(2,989)(3,201)
Gross profit:3,1654,8966,5664,095
Operating expenses(5,195)(7,507)(10,407)(10,235)
Operating loss:(2,030)(2,611)(3,841)(6,140)
Nonoperating income (expense)(1,037)(1,218)170(6,632)
Interest and debt expense1,174 11(215)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(1,174) (11)215
Loss from continuing operations before equity method investments, income taxes:(3,067)(3,829)(3,671)(12,772)
Income from equity method investments 734  
Loss from continuing operations before income taxes:(3,067)(3,095)(3,671)(12,772)
Income tax expense (benefit) (66)(5,667)3,186
Net loss:(3,067)(3,161)(9,338)(9,586)
Net income attributable to noncontrolling interest23   
Other undisclosed net loss attributable to parent (734)  
Net loss available to common stockholders, diluted:(3,044)(3,895)(9,338)(9,586)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(3,067)(3,161)(9,338)(9,586)
Comprehensive loss:(3,067)(3,161)(9,338)(9,586)
Comprehensive income, net of tax, attributable to noncontrolling interest23   
Comprehensive loss, net of tax, attributable to parent:(3,044)(3,161)(9,338)(9,586)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: